0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Nonablative Facial Remodeling:  Erythema Reduction and Histologic Evidence of New Collagen Formation Using a 300-Microsecond 1064-nm Nd:YAG Laser FREE

Chrys D. Schmults; Robert Phelps, MD; David J. Goldberg, MD
Arch Dermatol. 2004;140(11):1373-1376. doi:10.1001/archderm.140.11.1373.
Text Size: A A A
Published online

Background  A variety of nonablative lasers have been used to improve skin color and toning. Evidence of new collagen has been seen. Using blinded observer analysis of electron microscopic changes, we have documented the effect of a nonablative Nd:YAG laser on collagen production and its relationship to patient age.

Observations  Ultrastructural analysis of 9 patients showed a decrease in overall collagen fiber diameter in the papillary dermis at 1 month and 3 months after 3 treatment sessions. This is consistent with the formation of new collagen. Younger patients had a greater decrease in collagen fiber diameter compared with older patients. The change in collagen fiber diameter with time as well as the relationship between that change and the patient’s age were statistically significant (P<.001). Photographic evaluation showed that those patients with preexisting erythema showed improvement in erythema along with an associated improvement in skin quality. There were no adverse events.

Conclusions  Microsecond Nd:YAG lasers appear to be safe for nonablative laser remodeling. Our study indicates that microsecond Nd:YAG lasers can produce new collagen formation in the papillary dermis. In addition, the condition of patients with erythema may be improved. Younger patients may form more new collagen compared with older patients with photodamage.

Figures in this Article

Both nanosecond (Q-switched) and millisecond (long-pulsed) Nd:YAG lasers are currently used for nonablative dermal remodeling.17 They are thought to stimulate new collagen production by producing a thermal injury to the dermis that initiates a wound-healing response.8 During wound healing, procollagen and type III collagen fibers are produced initially and have a small diameter. Later in the wound-healing process, thicker type I collagen fibers are made and cross-linking occurs, leading to an increase in the average diameter of collagen fibers in the dermis.9 Collagen fiber diameter can be measured via electron microscopy (EM). Electron microscopy studies of nonablative lasers such as the 585-nm flashlamp pulsed dye laser have shown a decrease in diameter of dermal collagen fibers after nonablative laser therapy.10 A decrease in collagen fiber diameter has been associated with production of new collagen,8,9 which is thought to increase skin firmness and improve skin texture in patients after treatment.

Recently, intermediate pulsed Nd:YAG lasers have been developed with pulse durations in the microsecond range. We investigated one of these new microsecond Nd:YAG lasers to determine its safety and efficacy in nonablative dermal remodeling by using clinical photographs and EM analysis of dermal collagen fibers.

Ten women aged 28 to 67 years with erythema and/or fine lines were enrolled in a study approved by the Pascack Valley Hospital (Westwood, NJ) institutional review committee. Subjects had Fitzpatrick skin types I through III. After signing a consent form, all subjects’ faces (excluding the periorbital area) and jawline were treated 3 times at 2-week intervals with a 1064-nm Nd:YAG laser (CoolGlide Vantage; Cutera, Brisbane, Calif). Prior to treatment, the skin was cleansed with a standard bacteriostatic soap and water. Subjects’ eyes were protected with stainless steel external ocular shields, and laser pulses were applied on the skin adjacent to but outside the orbital rim. The laser parameters were set to a fluence of 13 J/cm2, a pulse duration of 300 microseconds, and a spot size of 5 mm. A smooth, rapid painting motion was used to administer treatment, with the tip of the instrument 2 to 4 cm above the skin surface. Based on this separation from the skin, the actual laser beam at the skin surface is 6 to 7 mm in diameter, with corresponding fluences from 9 to 7 J/cm2, respectively. No cooling was performed.

The face was treated in 4 sections, with a combined total of 12 000 to 14 700 light pulses applied per treatment. The pulses were applied at a rate of 7 Hz with a continuous motion of the handpiece at approximately 8 cm/s such that the pulses had little, if any, overlap. This was accomplished through a back and forth motion in 1 direction, combined with gradual motion in the perpendicular direction. Within each section of the face, repeated passes were made. The end point was determined based on the number of pulses. Each entire treatment consisted of approximately 30 minutes.

Two-millimeter punch biopsy specimens were obtained at baseline and at 1 and 3 months after final treatment. Biopsy specimens were taken from the infra-auricular sun-exposed area. Sequential biopsy specimens were taken nearly adjacent to each other. Collagen fibers from the papillary dermis were visualized and photographed via EM by previously described methods.11,12 Collagen fiber diameter of longitudinally cut fibers was measured directly on the photographs in millimeters, then adjusted for magnification to give a diameter in nanometers. For each biopsy specimen, a blinded physician observer measured and recorded the diameter of collagen fibers from 5 photographs. Ten fibers were measured per photo for a total of 50 collagen fiber measurements per biopsy specimen. The measurements for each specimen were averaged and then a mean fiber diameter for all patients was calculated for each time point.

Statistical analysis of the collagen fiber measurements was performed using SAS, version 8.2 (SAS Inc, Cary, NC), on a UNIX platform. The fiber diameter reduction from baseline to 1 and 3 months was tested using the 1-sided paired t test. Linear regression analyses were performed, and Pearson correlation coefficients were calculated for the correlations between age and change in fiber size from baseline to 1 and 3 months. An analysis of variance (ANOVA) was performed to analyze the relationship between the fiber size distributions and the time point.

In addition to the ultrastructural measurements, subjects were photographed at baseline, prior to each treatment, and at 1 and 3 months after final treatment. Digital photography with identical lighting conditions was used for all photographs. Photographs were evaluated by 2 nonblinded physicians, and changes in erythema and skin quality were assessed at each time point as compared with baseline. At each visit, patients were assessed for adverse effects, including erythema, edema, purpura, blistering, pigmentary changes, and scarring. At each visit, all subjects were asked if they had any adverse events between visits.

There were no adverse events reported in this study. Treatments were well tolerated by all patients, with minimal discomfort. Transient erythema occurred after almost all treatments but disappeared within hours of treatment.

One patient was lost to follow-up after the first treatment and was excluded from all analysis. One patient was excluded from clinical analysis owing to photographic errors but was still included in the EM collagen fiber analysis.

Four patients had noticeable erythema prior to treatment. All 4 of these patients had a reduction in erythema at 1- and 3-month follow-up visits as evidenced by photographic evaluation. The improvement was greatest at 3 months. Skin texture was also improved in areas of erythema reduction as evidenced by photographic evaluation (Figure 1 and Figure 2).

Place holder to copy figure label and caption
Figure 1.

A, Erythema of the face before treatment with a 300-microsecond 1064-nm Nd:YAG laser; B, 3 months after final treatment.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

A, Erythema of the face before treatment with a 300-microsecond 1064-nm Nd:YAG laser; B, 3 months after final treatment.

Graphic Jump Location

Mean collagen fiber diameter decreased compared with baseline at 1 and 3 months after the final treatment (Table) (Figure 3) in 7 of 9 patients. This difference approached statistical significance at 1 month (P = .08) and was significant at 3 months (P = .03). The relationship between fiber width distribution and the 3 time points (Figure 3) was significant (P = .02) by the ANOVA. An example set of EM photographs demonstrating the decrease in fiber size is shown in Figure 4.

Place holder to copy figure label and caption
Figure 3.

Mean percentage of collagen fibers of varying sizes before and 1 and 3 months after treatment.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.

Electron micrographs of collagen fibers in the papillary dermis in 1 patient (A, pretreatment; B, 1 month after treatment; and C, 3 months after treatment [reticulated background represents either proteoglycans or glycosoaminoglycans]). The collagen fibers show typical periodicity and are cut longitudinally and transversely. There is gradual decrease in average width from pretreatment to 3 months (scale bar, 320 nm; original magnification ×40 000). Typical collagen fibers are labeled “C.”

Graphic Jump Location
Table Graphic Jump LocationTable. Mean Diameters of Collagen Fibers

The decrease in mean collagen fiber diameter appeared to be related to age. Younger patients appeared to have a greater decrease in collagen fiber diameter at 3 months (Figure 5). The linear regression analysis showed that for regression between subject age and change in fiber size from baseline to 1 month, the P value is. 01 (Pearson correlation coefficient, –0.78), and to 3 months the P value is <.001 (Pearson correlation coefficient, –0.91).

Place holder to copy figure label and caption
Figure 5.

Mean decrease in collagen fiber diameter 3 months after final treatment.

Graphic Jump Location

The microsecond Nd:YAG laser investigated in this study appears to be safe for Fitzpatrick skin types I through III when used within the parameters studied and may be useful for reducing facial erythema and improving skin texture. The significant decrease in collagen fiber diameter seen by EM analysis at 3 months after treatment suggests that new collagen is being produced.8,9 This is consistent with an early wound-healing response in which thin procollagen and/or collagen III fiber production is increased in the papillary dermis. This new collagen production may be responsible for the improvement in skin quality seen after nonablative treatments.

Older patients appeared to have little to no decrease in collagen fiber diameter after treatment. This may suggest that older patients do not produce new collagen in response to nonablative laser therapy. The oldest patient in this study (patient 7: age, 67 years) actually showed an increase in collagen fiber diameter. Marked solar elastosis was present microscopically in all 3 biopsy specimens from this patient. Elastosis can impede accurate measurement of collagen fiber diameters, making data analysis difficult to interpret by our methods. When the data for patients 58 years and younger (n = 8) were analyzed, the significance of the decrease in mean collagen fiber diameter was more evident with baseline mean diameter of 63.6 nm, 1-month diameter of 57.2 nm, and 3-month diameter of 54.0 nm. The difference between baseline and 1-month diameters (6.4 nm) was statistically significant (P = .04), as was the difference between baseline and 3-month diameters (9.5 nm) (P = .007).

It is possible that elastosis can block laser energy from hitting its targets and thereby inhibit its effectiveness in stimulating dermal remodeling. This may be why the 2 oldest patients in our study did not show a decrease in collagen fiber diameter. Older patients with photodamage may have minimal new collagen production in response to therapy. Anecdotal reports from clinicians indicate that younger patients with less photoaging have the greatest improvement from nonablative laser therapies. This study indicates that microsecond Nd:YAG lasers can reduce facial erythema and improve skin texture. The skin textural changes may be similar to those reported with a variety of nonablative lasers.1316 A statistically significant reduction in collagen fiber diameter after treatment indicates formation of new collagen. This may be 1 mechanism by which microsecond Nd:YAG lasers exert their clinical effects. Older patients with photodamage had less of a reduction in collagen fiber diameter. This may reflect less new collagen formation, which may lead to reduced clinical effects in such patients.

Further work remains to determine the role that age and photodamage may play in dermal remodeling and clinical effectiveness after nonablative laser resurfacing. Studies are also needed to better define the mechanisms by which nonablative laser resurfacing exerts effects on collagen and other components of the dermal matrix.

Correspondence: David J. Goldberg, MD, Skin Laser and Surgery Specialists of New York and New Jersey, 20 Prospect Ave, Suite 702, Hackensack, NJ 07601 (drdavidgoldberg@skinandlasers.com).

Accepted for Publication: June 2, 2004.

Funding/Support: This study was funded, in part, by Cutera Inc, Brisbane, Calif, the makers of the CoolGlide Vantage laser used in this study.

Financial Disclosure: None.

Goldberg  DJWhitworth  J Laser skin resurfacing with the Q-switched Nd:YAG laser Dermatol Surg 1997;23903- 907
PubMed
Goldberg  DJMetzler  C Skin resurfacing utilizing a low-fluence Nd:YAG laser J Cutan Laser Ther 1999;123- 27
PubMed
Goldberg  DJ Non-ablative subsurface remodeling: clinical and histologic evaluation of a 1320-nm Nd:YAG laser J Cutan Laser Ther 1999;1153- 157
PubMed
Goldberg  DJ Subdermal resurfacing Oper Tech Oculoplst Orbital Reconstr Surg 1999;2188- 193
Goldberg  DJ Nonablative resurfacing Clin Plast Surg 2000;27287- 292
PubMed
Goldberg  DJ Full-face nonablative dermal remodeling with a 1320nm Nd:YAG laser Dermatol Surg 2000;26915- 918
PubMed
Goldberg  DJSilapunt  S Histologic evaluation of a Q-switched Nd:YAG laser in the nonablative treatment of wrinkles Dermatol Surg 2001;27744- 746
PubMed
Clark  RA Cutaneous tissue repair: basic biological considerations: I J Am Acad Dermatol 1985;13701- 725
PubMed
Clark  RA Basics of cutaneous wound repair J Dermatol Surg Oncol 1993;19693- 706
PubMed
Goldberg  DJTan  MSarradet  MD  et al.  Nonablative dermal remodeling with a 585nm, 350μsec flashlamp pulsed dye laser Dermatol Surg 2003;29161- 164
PubMed
Fleischmajer  RTimpl  RTuderman  L  et al.  Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin Proc Natl Acad Sci U S A 1981;787360- 7364
PubMed
Phelps  RGDaian  CShibata  SFleischmajer  RBona  CA Induction of skin fibrosis and autoantibodies by infusion of immunocompetent cells from tight skin mice into C57BL/6 Pa/Pa mice J Autoimmun 1993;6701- 718
PubMed
Trelles  MAAllones  ILuna  R Facial rejuvenation with a nonablative 1320-nm Nd:YAG laser Dermatol Surg 2001;27111- 116
PubMed
Trelles  MA Short and long-term follow-up of nonablative 1320-nm Nd:YAG laser facial rejuvenation Dermatol Surg 2001;27781- 782
PubMed
Lupton  JRWilliams  CMAlster  TS Nonablative laser skin resurfacing using a 1450-nm erbium glass laser Dermatol Surg 2002;28833- 835
PubMed
Tanzi  ELAlster  TS Comparison of a 1450-nm diode laser and a 1320-nm Nd:YAG laser in the treatment of atrophic facial scars Dermatol Surg 2004;30152- 157
PubMed

Figures

Place holder to copy figure label and caption
Figure 1.

A, Erythema of the face before treatment with a 300-microsecond 1064-nm Nd:YAG laser; B, 3 months after final treatment.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

A, Erythema of the face before treatment with a 300-microsecond 1064-nm Nd:YAG laser; B, 3 months after final treatment.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Mean percentage of collagen fibers of varying sizes before and 1 and 3 months after treatment.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.

Electron micrographs of collagen fibers in the papillary dermis in 1 patient (A, pretreatment; B, 1 month after treatment; and C, 3 months after treatment [reticulated background represents either proteoglycans or glycosoaminoglycans]). The collagen fibers show typical periodicity and are cut longitudinally and transversely. There is gradual decrease in average width from pretreatment to 3 months (scale bar, 320 nm; original magnification ×40 000). Typical collagen fibers are labeled “C.”

Graphic Jump Location
Place holder to copy figure label and caption
Figure 5.

Mean decrease in collagen fiber diameter 3 months after final treatment.

Graphic Jump Location

Tables

Table Graphic Jump LocationTable. Mean Diameters of Collagen Fibers

References

Goldberg  DJWhitworth  J Laser skin resurfacing with the Q-switched Nd:YAG laser Dermatol Surg 1997;23903- 907
PubMed
Goldberg  DJMetzler  C Skin resurfacing utilizing a low-fluence Nd:YAG laser J Cutan Laser Ther 1999;123- 27
PubMed
Goldberg  DJ Non-ablative subsurface remodeling: clinical and histologic evaluation of a 1320-nm Nd:YAG laser J Cutan Laser Ther 1999;1153- 157
PubMed
Goldberg  DJ Subdermal resurfacing Oper Tech Oculoplst Orbital Reconstr Surg 1999;2188- 193
Goldberg  DJ Nonablative resurfacing Clin Plast Surg 2000;27287- 292
PubMed
Goldberg  DJ Full-face nonablative dermal remodeling with a 1320nm Nd:YAG laser Dermatol Surg 2000;26915- 918
PubMed
Goldberg  DJSilapunt  S Histologic evaluation of a Q-switched Nd:YAG laser in the nonablative treatment of wrinkles Dermatol Surg 2001;27744- 746
PubMed
Clark  RA Cutaneous tissue repair: basic biological considerations: I J Am Acad Dermatol 1985;13701- 725
PubMed
Clark  RA Basics of cutaneous wound repair J Dermatol Surg Oncol 1993;19693- 706
PubMed
Goldberg  DJTan  MSarradet  MD  et al.  Nonablative dermal remodeling with a 585nm, 350μsec flashlamp pulsed dye laser Dermatol Surg 2003;29161- 164
PubMed
Fleischmajer  RTimpl  RTuderman  L  et al.  Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin Proc Natl Acad Sci U S A 1981;787360- 7364
PubMed
Phelps  RGDaian  CShibata  SFleischmajer  RBona  CA Induction of skin fibrosis and autoantibodies by infusion of immunocompetent cells from tight skin mice into C57BL/6 Pa/Pa mice J Autoimmun 1993;6701- 718
PubMed
Trelles  MAAllones  ILuna  R Facial rejuvenation with a nonablative 1320-nm Nd:YAG laser Dermatol Surg 2001;27111- 116
PubMed
Trelles  MA Short and long-term follow-up of nonablative 1320-nm Nd:YAG laser facial rejuvenation Dermatol Surg 2001;27781- 782
PubMed
Lupton  JRWilliams  CMAlster  TS Nonablative laser skin resurfacing using a 1450-nm erbium glass laser Dermatol Surg 2002;28833- 835
PubMed
Tanzi  ELAlster  TS Comparison of a 1450-nm diode laser and a 1320-nm Nd:YAG laser in the treatment of atrophic facial scars Dermatol Surg 2004;30152- 157
PubMed

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics